Published in
Elsevier, Heart, Lung and Circulation, 9(29), p. 1310-1317, 2020
DOI: 10.1016/j.hlc.2019.03.007
Links
Tools
Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 